Chapter 13. Acetylcholine Receptor Antibody: Clinical and Experimental Aspects

  1. David Evered and
  2. Julie Whelan
  1. John Newsom-Davis,
  2. Angela Vincent and
  3. Nick Willcox

Published Online: 30 MAY 2008

DOI: 10.1002/9780470720721.ch13

Ciba Foundation Symposium 90 - Receptors, Antibodies and Disease

Ciba Foundation Symposium 90 - Receptors, Antibodies and Disease

How to Cite

Newsom-Davis, J., Vincent, A. and Willcox, N. (1982) Acetylcholine Receptor Antibody: Clinical and Experimental Aspects, in Ciba Foundation Symposium 90 - Receptors, Antibodies and Disease (eds D. Evered and J. Whelan), John Wiley & Sons, Ltd., Chichester, UK. doi: 10.1002/9780470720721.ch13

Author Information

  1. Department of Neurological Science, The Royal Free Hospital School of Medicine, Pond Street. London NW.3 2QG, and Institute of Neurology, National Hospital for Nervous Diseases, Queen Square, London WCIN 3BG, UK

Publication History

  1. Published Online: 30 MAY 2008
  2. Published Print: 1 JAN 1982

ISBN Information

Print ISBN: 9780272796542

Online ISBN: 9780470720721

SEARCH

Keywords:

  • acetylcholine receptor antibody;
  • thymic pathology;
  • myasthenic patients;
  • myasthenia gravis;
  • clinical heterogeneity

Summary

This Chapter Contains Section Title:

  • Clinical Heterogeneity in Myasthenia Gravis

  • Cellular Mechanisms in Anti-Ach Receptor Antibody Production

  • Conclusions

  • Reference

  • Discussion

  • Reference